Universität zu Köln

Goeser, Felix ORCID: 0000-0003-3190-9981, Sifft, Barbara, Stein-Thoeringer, Christoph, Farowski, Fedja, Strassburg, Christian P., Brossart, Peter, Higgins, Paul G. ORCID: 0000-0001-8677-9454, Scheid, Christoph, Wolf, Dominik, Holderried, Tobias A. W., Vehreschild, Maria J. G. T. and Cruz Aguilar, Marta Rebeca (2021). Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers. Eur. J. Haematol., 107 (2). S. 229 - 246. HOBOKEN: WILEY. ISSN 1600-0609

Full text not available from this repository.

Abstract

Rationale Steroid refractory graft-vs-host disease (sr-GvHD) represents a challenging complication after allogeneic hematopoietic cell transplantation (allo-HCT). Intestinal microbiota (IM) diversity and dysbiosis were identified as influencing factors for the development of acute GvHD. Fecal microbiota transfer (FMT) is hypothesized to restore IM dysbiosis, but there is limited knowledge about the significance of FMT in the treatment of sr-GvHD. Objectives We studied the effects of FMT on sr-GvHD in allo-HCT patients from two German tertiary clinical centers (n = 11 patients; period: March 2017 until July 2019). To assess safety and clinical efficacy, we analyzed clinical data pre- and post-FMT (day -14 to +30 relative to FMT). Moreover, IM were analyzed in donor samples and in a subset of patients pre- and post-FMT by 16S rRNA sequencing. Results Post-FMT, we observed no intervention-associated, systemic inflammatory responses and only minor side effects (5/11 patients: abdominal pain and transformation of peristalsis-each 3/11 and vomiting-1/11). Stool frequencies and volumes were significantly reduced [pre- vs post-FMT (d14): P < .05, respectively] as well as clear attenuation regarding both grading and staging of sr-GvHD was present upon FMT. Moreover, IM analyses revealed an increase of alpha diversity as well as a compositional shifts toward the donor post-FMT. Conclusions In our study, we observed positive effects on sr-GVHD after FMT without the occurrence of major adverse events. Although these findings are in line with published data on beneficial effects of FMT in sr-GvHD, further randomized clinical studies are urgently needed to better define the clinical validity including mode of action.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Goeser, Felix UNSPECIFIED orcid.org/0000-0003-3190-9981 UNSPECIFIED Sifft, Barbara UNSPECIFIED UNSPECIFIED UNSPECIFIED Stein-Thoeringer, Christoph UNSPECIFIED UNSPECIFIED UNSPECIFIED Farowski, Fedja UNSPECIFIED UNSPECIFIED UNSPECIFIED Strassburg, Christian P. UNSPECIFIED UNSPECIFIED UNSPECIFIED Brossart, Peter UNSPECIFIED UNSPECIFIED UNSPECIFIED Higgins, Paul G. UNSPECIFIED orcid.org/0000-0001-8677-9454 UNSPECIFIED Scheid, Christoph UNSPECIFIED UNSPECIFIED UNSPECIFIED Wolf, Dominik UNSPECIFIED UNSPECIFIED UNSPECIFIED Holderried, Tobias A. W. UNSPECIFIED UNSPECIFIED UNSPECIFIED Vehreschild, Maria J. G. T. UNSPECIFIED UNSPECIFIED UNSPECIFIED Cruz Aguilar, Marta Rebeca UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-596057
DOI:	10.1111/ejh.13642
Journal or Publication Title:	Eur. J. Haematol.
Volume:	107
Number:	2
Page Range:	S. 229 - 246
Date:	2021
Publisher:	WILEY
Place of Publication:	HOBOKEN
ISSN:	1600-0609
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language CLOSTRIDIUM-DIFFICILE INFECTION; GUT MICROBIOTA; GASTROINTESTINAL GVHD; STEROID-RESISTANT; CELL TRANSPLANT; RECURRENT; ANTIBIOTICS; MARKERS; INFLAMMATION; EFFICACY Multiple languages Hematology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/59605